| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-07 |
| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-06 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-06 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |